{"category":{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-05T04:09:36.463Z","updated_at":"2026-09-05T04:09:36.463Z","example":false,"profile_url":"/categories/therapeutics","is_stub":true,"member_count":58,"member_counts":{"product":58}},"members":[{"listing_type":"product","name":"Novadip NVD003","slug":"novadip-nvd003","tagline":"Autologous cell therapy for congenital pseudarthrosis of the tibia","description":"NVD003 is Novadip’s autologous cell-based regenerative therapy candidate for congenital pseudarthrosis of the tibia, advancing through pivotal Phase 3 clinical studies in the United States and Europe.","url":"https://novadip.com/pipeline/","is_stealth":false,"normalized_domain":"novadip.com","normalized_url_key":"novadip.com/pipeline","parent_slug":"novadip-biosciences","parent":{"slug":"novadip-biosciences","name":"Novadip Biosciences","listing_type":"company","profile_url":"/companies/novadip-biosciences"},"type_data":{"product_kind":"other"},"logo":"https://novadip.com/wp-content/uploads/2022/09/cropped-20200406-Novadip-Logo-vertical-270x270.png","links":[],"entry_points":[{"kind":"homepage","url":"https://novadip.com/pipeline/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://novadip.com/pipeline/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"79525441-e9ca-4e7d-b365-f8a63bdd0ed5"},"categories":["Biotechnology","Regenerative Medicine","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-21T14:53:45.761Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-21T14:53:45.761Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/categories/biotechnology"},{"kind":"product_category","slug":"regenerative-medicine","name":"Regenerative Medicine","note":null,"profile_url":"/categories/regenerative-medicine"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-21T14:53:45.761Z","updated_at":"2026-09-21T14:53:45.761Z"}},{"listing_type":"product","name":"Linsitinib","slug":"linsitinib","tagline":"Oral therapy candidate for thyroid eye disease","description":"Linsitinib is Sling Therapeutics' lead pipeline program in development as a late-stage oral therapy for thyroid eye disease (TED).","url":"https://slingtx.com/","is_stealth":false,"normalized_domain":"slingtx.com","normalized_url_key":"slingtx.com","parent_slug":"sling-therapeutics","parent":{"slug":"sling-therapeutics","name":"Sling Therapeutics","listing_type":"company","profile_url":"/companies/sling-therapeutics"},"type_data":{"product_kind":"other","use_cases":["Thyroid eye disease treatment"]},"logo":"https://slingtx.com/wp-content/uploads/2021/11/cropped-favicon2_1-32x32.png","links":[],"entry_points":[{"kind":"homepage","url":"https://slingtx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://slingtx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"6a3ac73d-6229-4568-ab7f-586b5b43f2e7"},"categories":["Biotech","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-18T02:16:56.300Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-18T02:16:56.300Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-18T02:16:56.300Z","updated_at":"2026-09-18T02:16:56.300Z"}},{"listing_type":"product","name":"Forever Labs","slug":"forever-labs-service","tagline":"A stem cell banking service that collects and cryopreserves adult stem cells in-office with a board-certified physician for use in current and future…","description":"Forever Labs offers annual and lifetime membership plans in which a board-certified physician collects adult stem cells during an in-office procedure; cells are cryopreserved and stored in ISO-accredited biobanks. Members manage their stored cells and storage location through a client portal and the Forever mobile app (iOS and Android). Annual membership is FSA/HSA eligible and can be cancelled at any time. The company operates one of the largest regenerative care networks in the US with providers nationwide since 2015.\n\nForever Labs is a product of Forever Labs.","url":"https://www.foreverlabs.com/","is_stealth":false,"normalized_domain":"foreverlabs.com","normalized_url_key":"foreverlabs.com","parent_slug":"forever-labs","parent":{"slug":"forever-labs","name":"Forever Labs","listing_type":"company","profile_url":"/companies/forever-labs"},"type_data":{"product_kind":"service","pricing_model":"subscription","platforms":["web","ios","android"],"free_tier":false,"open_source":false,"pricing_url":"https://www.foreverlabs.com/","use_cases":["Adult stem cell banking for future regenerative therapy","Proactive longevity health management"]},"logo":null,"links":[],"entry_points":[{"kind":"signup","url":"https://www.foreverlabs.com/","audience":"human","primary":false,"listed_by":"community","on_listing_domain":true},{"kind":"pricing","url":"https://www.foreverlabs.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"signup","url":"https://www.foreverlabs.com/","audience":"human","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Anti-Aging","Consumer Health","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":"Annual membership (includes collection, first year storage, portal access); lifetime membership available as one-time payment; FSA/HSA eligible","twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:39:46.898Z","added_via":"web","geo":{"keywords":["Forever Labs","Forever Labs","Healthcare","Biotech","Anti-Aging","Consumer Health","Therapeutics"],"canonical_facts":["Product of Forever Labs","Pricing (per product site): Annual membership (includes collection, first year storage, portal access); lifetime membership available as one-time payment; FSA/HSA eligible"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:39:46.898Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"anti-aging","name":"Anti-Aging","note":null,"profile_url":"/categories/anti-aging"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"consumer-health","name":"Consumer Health","note":null,"profile_url":"/categories/consumer-health"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:39:46.898Z","updated_at":"2026-09-05T07:39:46.898Z"}},{"listing_type":"product","name":"Persephone Biosciences","slug":"persephone-biosciences-product","tagline":"Clinically validated synbiotic probiotic and prebiotic supplement formulated specifically for babies' gut microbiome.","description":"Persephone Biosciences makes a first-of-its-kind synbiotic baby supplement combining keystone Bifidobacterium probiotic strains with an HMO-like prebiotic blend found in human breast milk, plus 100% daily recommended Vitamin D for infants. Validated in the ARTEMIS randomized controlled trial published in Pediatric Research (Nature Portfolio), it is third-party tested, Deep DNA sequenced, and Clean Label Project certified. The company's My Baby Biome study found 9 out of 10 US babies lack essential gut bacteria needed for healthy immune and digestive development.\n\nPersephone Biosciences is a product of Persephone Biosciences.","url":"https://persephone.bio/","is_stealth":false,"normalized_domain":"persephone.bio","normalized_url_key":"persephone.bio","parent_slug":"persephone-biosciences","parent":{"slug":"persephone-biosciences","name":"Persephone Biosciences","listing_type":"company","profile_url":"/companies/persephone-biosciences"},"type_data":{"product_kind":"other","pricing_model":"subscription","platforms":["web"],"free_tier":false,"open_source":false,"use_cases":["infant gut microbiome support","baby immune development","digestive health for infants","probiotic supplementation for babies"]},"logo":null,"links":[],"entry_points":[{"kind":"signup","url":"https://persephone.bio/","audience":"human","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"signup","url":"https://persephone.bio/","audience":"human","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Consumer Health and Wellness","Biotech","Baby Health","Therapeutics","AI-powered Drug Discovery","COVID-19"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:32:14.939Z","added_via":"web","geo":{"keywords":["Persephone Biosciences","Persephone Biosciences","Healthcare","Consumer Health and Wellness","Biotech","Baby Health","Therapeutics","AI-powered Drug Discovery","COVID-19"],"canonical_facts":["Product of Persephone Biosciences"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:32:14.939Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/categories/ai-powered-drug-discovery"},{"kind":"product_category","slug":"baby-health","name":"Baby Health","note":null,"profile_url":"/categories/baby-health"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"consumer-health-and-wellness","name":"Consumer Health and Wellness","note":null,"profile_url":"/categories/consumer-health-and-wellness"},{"kind":"product_category","slug":"covid-19","name":"COVID-19","note":null,"profile_url":"/categories/covid-19"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:32:14.939Z","updated_at":"2026-09-05T07:32:14.939Z"}},{"listing_type":"product","name":"Nectome","slug":"nectome-service","tagline":"Post-mortem whole-body preservation service that stores the brain's neural connections for potential future revival.","description":"Nectome offers post-mortem whole-body preservation using aldehyde-stabilized cryopreservation to preserve the brain's connectome at extremely high quality after legal death, with storage at −135°C indefinitely. The approach aims to maintain the structural basis of memory, skills, and personality intact for hundreds of years until scanning and emulation technology becomes feasible. Nectome positions preservation as a last experimental option for people nearing end of life who wish to endure into the distant future.\n\nNectome is a product of Nectome.","url":"https://nectome.com/","is_stealth":false,"normalized_domain":"nectome.com","normalized_url_key":"nectome.com","parent_slug":"nectome","parent":{"slug":"nectome","name":"Nectome","listing_type":"company","profile_url":"/companies/nectome"},"type_data":{"product_kind":"service","platforms":["web"],"free_tier":false,"open_source":false,"use_cases":["brain preservation for future revival","connectome preservation","cryopreservation at death"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://nectome.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://nectome.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Neurotechnology","Biotech","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:31:41.157Z","added_via":"web","geo":{"keywords":["Nectome","Nectome","Healthcare","Neurotechnology","Biotech","Therapeutics"],"canonical_facts":["Product of Nectome"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:31:41.157Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"neurotechnology","name":"Neurotechnology","note":null,"profile_url":"/categories/neurotechnology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:31:41.157Z","updated_at":"2026-09-05T07:31:41.157Z"}},{"listing_type":"product","name":"Mind Emulation Foundation","slug":"mind-emulation-foundation-product","tagline":"Nonprofit research organization funding scientific research to accelerate human mind emulation and brain preservation.","description":"The Mind Emulation Foundation funds and conducts scientific research toward human mind emulation, which involves preserving the brain's connectome (all neural connections) after legal death for potential future digital revival. The foundation advocates for both destructive scanning (using aldehyde-stabilized cryopreservation) and non-destructive scanning approaches (advanced MRI). Supporters can sign the Mind Emulation Manifesto on the website, committing to supporting research and considering mind preservation.\n\nMind Emulation Foundation is a product of Mind Emulation Foundation.","url":"https://mindemulation.org/","is_stealth":false,"normalized_domain":"mindemulation.org","normalized_url_key":"mindemulation.org","parent_slug":"mind-emulation-foundation","parent":{"slug":"mind-emulation-foundation","name":"Mind Emulation Foundation","listing_type":"company","profile_url":"/companies/mind-emulation-foundation"},"type_data":{"product_kind":"other","platforms":["web"],"open_source":false,"use_cases":["mind emulation research funding","brain preservation advocacy","connectome mapping research"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://mindemulation.org/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://mindemulation.org/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Neurotechnology","Research","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:31:37.494Z","added_via":"web","geo":{"keywords":["Mind Emulation Foundation","Mind Emulation Foundation","Healthcare","Neurotechnology","Research","Therapeutics"],"canonical_facts":["Product of Mind Emulation Foundation"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:31:37.494Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"neurotechnology","name":"Neurotechnology","note":null,"profile_url":"/categories/neurotechnology"},{"kind":"product_category","slug":"research","name":"Research","note":null,"profile_url":"/categories/research"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:31:37.494Z","updated_at":"2026-09-05T07:31:37.494Z"}},{"listing_type":"product","name":"Macromoltek","slug":"macromoltek-service","tagline":"AI-driven computational platform for antibody discovery, design, and optimization for biotech and pharma partners.","description":"Macromoltek uses AI and computational modeling to accelerate antibody discovery and engineering for biotech and pharmaceutical partners. The platform supports projects from target identification through lead optimization using proprietary algorithms for epitope mapping, developability assessments, and structural optimization. The company offers flexible partnership models and direct expert collaboration to design antibodies tailored to specific targets, aiming to reduce experimental cycles and time-to-market.\n\nMacromoltek is a product of Macromoltek.","url":"https://www.macromoltek.com/","is_stealth":false,"normalized_domain":"macromoltek.com","normalized_url_key":"macromoltek.com","parent_slug":"macromoltek","parent":{"slug":"macromoltek","name":"Macromoltek","listing_type":"company","profile_url":"/companies/macromoltek"},"type_data":{"product_kind":"service","pricing_model":"project","free_tier":false,"open_source":false,"use_cases":["antibody discovery","antibody optimization","epitope mapping","drug candidate selection","therapeutic pipeline acceleration"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.macromoltek.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.macromoltek.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Drug Discovery","AI","Drug Discovery and Delivery","AI-powered Drug Discovery","Deep Learning","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:31:30.185Z","added_via":"web","geo":{"keywords":["Macromoltek","Macromoltek","Healthcare","Biotech","Drug Discovery","AI","Drug Discovery and Delivery","AI-powered Drug Discovery","Deep Learning","Therapeutics"],"canonical_facts":["Product of Macromoltek"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:31:30.185Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/categories/ai-powered-drug-discovery"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"deep-learning","name":"Deep Learning","note":null,"profile_url":"/categories/deep-learning"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:31:30.185Z","updated_at":"2026-09-05T07:31:30.185Z"}},{"listing_type":"product","name":"HepaTx","slug":"hepatx-product","tagline":"Stem cell-based regenerative medicine therapies for late-stage liver disease as an alternative to organ transplant.","description":"HepaTx is a Palo Alto-based biotech company developing stem cell-based treatments for end-stage liver disease aimed at replacing the need for organ transplants. Their scalable manufacturing process is designed to make liver regeneration both clinically and economically practical. The company is in the research and development stage with no commercially available product; they invite investment and career inquiries via their website.\n\nHepaTx is a product of Hepatx.","url":"https://hepatx.com/","is_stealth":false,"normalized_domain":"hepatx.com","normalized_url_key":"hepatx.com","parent_slug":"hepatx","parent":{"slug":"hepatx","name":"Hepatx","listing_type":"company","profile_url":"/companies/hepatx"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["liver disease treatment","alternative to liver transplant","regenerative medicine for end-stage liver failure"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://hepatx.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://hepatx.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:31:11.653Z","added_via":"web","geo":{"keywords":["HepaTx","Hepatx","Healthcare","Biotech","Therapeutics"],"canonical_facts":["Product of Hepatx"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:31:11.653Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:31:11.653Z","updated_at":"2026-09-05T07:31:11.653Z"}},{"listing_type":"product","name":"Circumvent Pharmaceuticals","slug":"circumvent-pharmaceuticals","tagline":"Precision medicines in development for neurodegenerative diseases, starting with CLN1 Batten Disease.","description":"Circumvent Pharmaceuticals is developing precision medicines for neurodegenerative diseases by studying the palmitoylome and its role in synaptic function. Their lead program targets CLN1 Batten Disease, a fatal childhood neurodegeneration caused by CLN1 gene mutations affecting palmitoylation. The company uses high-fidelity animal models and has developed insights into palmitoylome architecture that may broadly apply to rare and common neurodegenerative disorders. No approved treatments are currently available for CLN1 Batten Disease.\n\nCircumvent Pharmaceuticals is a product of Circumvent.","url":"https://www.circumventpharmaceuticals.com/","is_stealth":false,"normalized_domain":"circumventpharmaceuticals.com","normalized_url_key":"circumventpharmaceuticals.com","parent_slug":"circumvent","parent":{"slug":"circumvent","name":"Circumvent","listing_type":"company","profile_url":"/companies/circumvent"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Batten Disease treatment","neurodegenerative disease drug development"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.circumventpharmaceuticals.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.circumventpharmaceuticals.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Biotech","Neurotechnology","Genomics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:30:15.357Z","added_via":"web","geo":{"keywords":["Circumvent Pharmaceuticals","Circumvent","Healthcare","Therapeutics","Biotech","Neurotechnology","Genomics"],"canonical_facts":["Product of Circumvent"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:30:15.357Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"genomics","name":"Genomics","note":null,"profile_url":"/categories/genomics"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"neurotechnology","name":"Neurotechnology","note":null,"profile_url":"/categories/neurotechnology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:30:15.357Z","updated_at":"2026-09-05T07:30:15.357Z"}},{"listing_type":"product","name":"Sequence Bio","slug":"sequence-bio-service","tagline":"Genetics research platform discovering causal drug targets using Newfoundland's founder-effect population cohort.","description":"Sequence Bio uses the genetic founder effects in Newfoundland and Labrador—combined with detailed family health histories—to identify true causal genetic signals of disease for drug target discovery. The platform pairs genetic data with deep clinical records to move from statistical association to causal evidence, helping pharmaceutical partners identify the right drug targets and predictors of treatment response from the start. The company collaborates with local healthcare providers and global life sciences partners to translate insights into medicines.\n\nSequence Bio is a product of Sequence Bio.","url":"https://www.sequencebio.com/","is_stealth":false,"normalized_domain":"sequencebio.com","normalized_url_key":"sequencebio.com","parent_slug":"sequence-bio","parent":{"slug":"sequence-bio","name":"Sequence Bio","listing_type":"company","profile_url":"/companies/sequence-bio"},"type_data":{"product_kind":"service","free_tier":false,"open_source":false,"use_cases":["drug target discovery","clinical trial design","pharmacogenomics","rare disease genetics"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.sequencebio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.sequencebio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Genomics","Drug Discovery","Biotech","Drug Discovery and Delivery","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:28:46.421Z","added_via":"web","geo":{"keywords":["Sequence Bio","Sequence Bio","Healthcare","Genomics","Drug Discovery","Biotech","Drug Discovery and Delivery","Therapeutics"],"canonical_facts":["Product of Sequence Bio"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:28:46.421Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"genomics","name":"Genomics","note":null,"profile_url":"/categories/genomics"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:28:46.421Z","updated_at":"2026-09-05T07:28:46.421Z"}},{"listing_type":"product","name":"YCT-529","slug":"yct-529","tagline":"Investigational non-hormonal oral male contraceptive in Phase 2 clinical trials that suppresses sperm production by blocking retinoic acid receptor-alpha.","description":"YCT-529 is an oral, non-hormonal drug candidate from YourChoice Therapeutics that selectively antagonizes retinoic acid receptor-alpha (RAR-alpha) to suppress sperm production. Preclinical studies showed the effect reverses after stopping treatment. The compound is currently in Phase 2 clinical trials evaluating safety, tolerability, and pharmacokinetics and has not been approved by any regulatory authority.\n\nYCT-529 is a product of YourChoice Therapeutics.","url":"https://www.yourchoicetx.com/","is_stealth":false,"normalized_domain":"yourchoicetx.com","normalized_url_key":"yourchoicetx.com","parent_slug":"yourchoice-therapeutics","parent":{"slug":"yourchoice-therapeutics","name":"YourChoice Therapeutics","listing_type":"company","profile_url":"/companies/yourchoice-therapeutics"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Male contraception","Non-hormonal birth control for men"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.yourchoicetx.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.yourchoicetx.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Therapeutics","Drug Development","Health Tech"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:27:34.125Z","added_via":"web","geo":{"keywords":["YCT-529","YourChoice Therapeutics","Biotech","Healthcare","Therapeutics","Drug Development","Health Tech"],"canonical_facts":["Product of YourChoice Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:27:34.125Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-development","name":"Drug Development","note":null,"profile_url":"/categories/drug-development"},{"kind":"product_category","slug":"health-tech","name":"Health Tech","note":null,"profile_url":"/categories/health-tech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:27:34.125Z","updated_at":"2026-09-05T07:27:34.125Z"}},{"listing_type":"product","name":"Rejuvenation Technologies","slug":"rejuvenation-technologies","tagline":"mRNA-based telomere extension therapy using proprietary lipid nanoparticle delivery to reverse cellular aging in specific tissues.","description":"Rejuvenation Technologies is developing a clinical-stage therapeutic platform using modified mRNA delivered via proprietary lipid nanoparticles to temporarily activate telomerase and extend telomeres in targeted human cells. The company holds over 40 granted patents and has received more than $8M in grant funding since 2023. Target disease areas include pulmonary fibrosis, liver disease, and bone marrow failure. Preclinical studies have demonstrated reversal of 5+ years of telomere shortening in one day.\n\nRejuvenation Technologies is a product of Rejuvenation Technologies Inc..","url":"https://rejuvenationtech.com/","is_stealth":false,"normalized_domain":"rejuvenationtech.com","normalized_url_key":"rejuvenationtech.com","parent_slug":"rejuvenation-technologies-inc","parent":{"slug":"rejuvenation-technologies-inc","name":"Rejuvenation Technologies Inc.","listing_type":"company","profile_url":"/companies/rejuvenation-technologies-inc"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["pulmonary fibrosis treatment","liver disease treatment","bone marrow failure treatment","cellular age reversal"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://rejuvenationtech.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://rejuvenationtech.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Anti-Aging","Gene Therapy","Nanomedicine"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:23:46.414Z","added_via":"web","geo":{"keywords":["Rejuvenation Technologies","Rejuvenation Technologies Inc.","Healthcare","Therapeutics","Anti-Aging","Gene Therapy","Nanomedicine"],"canonical_facts":["Product of Rejuvenation Technologies Inc."]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:23:46.414Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"anti-aging","name":"Anti-Aging","note":null,"profile_url":"/categories/anti-aging"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/categories/nanomedicine"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:23:46.414Z","updated_at":"2026-09-05T07:23:46.414Z"}},{"listing_type":"product","name":"LEAH Labs","slug":"leah-labs-product","tagline":"CAR-T cell therapy company developing curative cancer treatments for dogs using GeneWeld precision gene editing and AI protein engineering.","description":"LEAH Labs (LifEngine Animal Health Laboratories) is the first company to achieve commercial remissions using CAR-T cell therapy in dogs with cancer, targeting B cell lymphoma. It uses the GeneWeld precision gene editing platform (invented by its founder during his PhD) and AI-driven de novo protein engineering to build affordable CAR-T therapies. Canine cancer mirrors human disease, making each dog remission a data point that accelerates human cancer therapy timelines. Clinical trials are fully funded with no cost to enrolled pet families; the next trial launches May 2026.\n\nLEAH Labs is a product of LEAH Labs.","url":"https://leahlabs.com/","is_stealth":false,"normalized_domain":"leahlabs.com","normalized_url_key":"leahlabs.com","parent_slug":"leah-labs","parent":{"slug":"leah-labs","name":"LEAH Labs","listing_type":"company","profile_url":"/companies/leah-labs"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Canine B cell lymphoma treatment","CAR-T therapy for dogs with cancer","Translational oncology for human therapies"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://leahlabs.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://leahlabs.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Cell Therapy","Healthcare","Veterinary","Drug Discovery","Therapeutics","CRISPR"],"stage":null,"founded_year":null,"location":null,"pricing":"Clinical trials fully funded; no cost to enrolled pet families","twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:22:42.124Z","added_via":"web","geo":{"keywords":["LEAH Labs","LEAH Labs","Biotech","Cell Therapy","Healthcare","Veterinary","Drug Discovery","Therapeutics","CRISPR"],"canonical_facts":["Product of LEAH Labs","Pricing (per product site): Clinical trials fully funded; no cost to enrolled pet families"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:22:42.124Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/categories/cell-therapy"},{"kind":"product_category","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/categories/crispr"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"},{"kind":"product_category","slug":"veterinary","name":"Veterinary","note":null,"profile_url":"/categories/veterinary"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:22:42.124Z","updated_at":"2026-09-05T07:22:42.124Z"}},{"listing_type":"product","name":"Intact Therapeutics","slug":"intact-therapeutics-product","tagline":"Clinical-stage biopharmaceutical company developing localized GI drug delivery technologies for gastrointestinal diseases.","description":"Intact Therapeutics is a clinical-stage biopharmaceutical company pioneering next-generation, localized drug delivery technologies for gastrointestinal diseases. Guided by a patient-centric mission, it develops innovative medicines that address significant unmet clinical needs in GI disorders with the goal of improving patient outcomes and quality of life.\n\nIntact Therapeutics is a product of Intact Therapeutics.","url":"https://intacttherapeutics.com/","is_stealth":false,"normalized_domain":"intacttherapeutics.com","normalized_url_key":"intacttherapeutics.com","parent_slug":"intact-therapeutics","parent":{"slug":"intact-therapeutics","name":"Intact Therapeutics","listing_type":"company","profile_url":"/companies/intact-therapeutics"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Localized GI drug delivery","Treatment of gastrointestinal disorders with unmet need"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://intacttherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://intacttherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Drug Delivery","Healthcare","Therapeutics","Gastrointestinal"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:22:21.397Z","added_via":"web","geo":{"keywords":["Intact Therapeutics","Intact Therapeutics","Biotech","Drug Delivery","Healthcare","Therapeutics","Gastrointestinal"],"canonical_facts":["Product of Intact Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:22:21.397Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/categories/drug-delivery"},{"kind":"product_category","slug":"gastrointestinal","name":"Gastrointestinal","note":null,"profile_url":"/categories/gastrointestinal"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:22:21.397Z","updated_at":"2026-09-05T07:22:21.397Z"}},{"listing_type":"product","name":"GEn1E Lifesciences","slug":"gen1e-lifesciences-product","tagline":"Clinical-stage Phase 2 biotech developing first-in-class precision therapies for rare and inflammatory diseases via the GRID AI platform.","description":"GEn1E Lifesciences is a clinical-stage Phase 2 company that advanced from early discovery to Phase 2 in 2.5 years using seed capital. It develops selective p38α:MK2 dual signal modulators with a differentiated mechanism of action that avoids non-specific immunosuppression. The lead asset GEn-1124 is in Phase 2 for ARDS. The proprietary GRID AI platform connects genes, pathways, proteins, diseases, and compounds via machine learning to accelerate drug discovery, yielding 21+ first-in-class compounds.\n\nGEn1E Lifesciences is a product of GEn1E Lifesciences.","url":"https://www.gen1e.com/","is_stealth":false,"normalized_domain":"gen1e.com","normalized_url_key":"gen1e.com","parent_slug":"gen1e-lifesciences","parent":{"slug":"gen1e-lifesciences","name":"GEn1E Lifesciences","listing_type":"company","profile_url":"/companies/gen1e-lifesciences"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Treatment for ARDS","Therapies for rare inflammatory diseases"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.gen1e.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.gen1e.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Drug Discovery","AI","Healthcare","Therapeutics","Artificial Intelligence"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:22:02.263Z","added_via":"web","geo":{"keywords":["GEn1E Lifesciences","GEn1E Lifesciences","Biotech","Drug Discovery","AI","Healthcare","Therapeutics","Artificial Intelligence"],"canonical_facts":["Product of GEn1E Lifesciences"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:22:02.263Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/categories/artificial-intelligence"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:22:02.263Z","updated_at":"2026-09-05T07:22:02.263Z"}},{"listing_type":"product","name":"ExcepGen RNAx","slug":"excepgen-rnax","tagline":"RNA-based vaccine platform that dampens excessive innate immune responses to improve tolerability of nucleic acid medicines.","description":"ExcepGen's RNAx platform is an mRNA-encoded protein that modulates cellular responses to RNA and lipid nanoparticles, aiming to reduce the overactive innate immune response associated with nucleic acid vaccines. The platform complements existing mRNA vaccine advances in capping, delivery, and non-natural nucleosides by addressing the cellular response to nucleic acids. Core initiatives include self-amplifying and trans-amplifying mRNA vaccines.\n\nExcepGen RNAx is a product of Excepgen.","url":"https://www.excepgen.com/","is_stealth":false,"normalized_domain":"excepgen.com","normalized_url_key":"excepgen.com","parent_slug":"excepgen","parent":{"slug":"excepgen","name":"Excepgen","listing_type":"company","profile_url":"/companies/excepgen"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["mRNA vaccine tolerability improvement","Nucleic acid medicine development","Innate immune modulation"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.excepgen.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.excepgen.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:15:28.979Z","added_via":"web","geo":{"keywords":["ExcepGen RNAx","Excepgen","Healthcare","Biotech","Therapeutics"],"canonical_facts":["Product of Excepgen"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:15:28.979Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:15:28.979Z","updated_at":"2026-09-05T07:15:28.979Z"}},{"listing_type":"product","name":"Asher Bio","slug":"asher-bio-product","tagline":"Cis-targeted immunotherapies that selectively activate specific immune cell types for cancer and autoimmune diseases.","description":"Asher Bio develops cis-targeted immunotherapies designed to activate only the immune cell types needed for a therapeutic effect. Their approach uses two-molecule targeting on the same immune cell—an immunomodulatory receptor and a cell-specific target—to achieve selectivity and reduce toxicity compared to conventional immunotherapies. Their lead program, etakafusp alfa (formerly AB248), is a cis-targeted IL-2 that preferentially activates CD8+ effector T cells, currently in Phase 1a/1b clinical trials with promising anti-tumor activity and a tolerable safety profile.\n\nAsher Bio is a product of Asher Bio.","url":"https://asherbio.com/","is_stealth":false,"normalized_domain":"asherbio.com","normalized_url_key":"asherbio.com","parent_slug":"asher-bio","parent":{"slug":"asher-bio","name":"Asher Bio","listing_type":"company","profile_url":"/companies/asher-bio"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Cancer immunotherapy","Autoimmune disease treatment","CD8+ T cell activation"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://asherbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://asherbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Therapeutics","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:14:28.300Z","added_via":"web","geo":{"keywords":["Asher Bio","Asher Bio","Healthcare","Biotech","Therapeutics","Oncology"],"canonical_facts":["Product of Asher Bio"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:14:28.300Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:14:28.300Z","updated_at":"2026-09-05T07:14:28.300Z"}},{"listing_type":"product","name":"1910 AI Platform","slug":"1910-ai-platform","tagline":"Multimodal AI platform for modality-agnostic drug discovery combining data, AI models, and lab automation.","description":"1910.ai is an AI-native biotech that integrates massive multimodal data, frontier AI models, and high-throughput lab automation into a unified infrastructure for small and large molecule therapeutics discovery. The platform is designed for pharmaceutical partners to build bespoke discovery modules at the level of data, AI models, compute, and interactive tools such as dashboards and conversational agents. The team consists of scientists and engineers focused on transforming drug development workflows.\n\n1910 AI Platform is a product of 1910.","url":"https://www.1910.ai/","is_stealth":false,"normalized_domain":"1910.ai","normalized_url_key":"1910.ai","parent_slug":"1910","parent":{"slug":"1910","name":"1910","listing_type":"company","profile_url":"/companies/1910"},"type_data":{"product_kind":"saas","pricing_model":"enterprise","platforms":["web"],"free_tier":false,"open_source":false,"use_cases":["small molecule drug discovery","large molecule therapeutics discovery","AI-driven compound screening","multimodal data integration for pharma","bespoke drug discovery module building"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.1910.ai/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.1910.ai/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["AI","Biotech","Healthcare","Drug Discovery","Therapeutics","AI-powered Drug Discovery"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:14:06.687Z","added_via":"web","geo":{"keywords":["1910 AI Platform","1910","AI","Biotech","Healthcare","Drug Discovery","Therapeutics","AI-powered Drug Discovery"],"canonical_facts":["Product of 1910"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:14:06.687Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/categories/ai-powered-drug-discovery"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:14:06.687Z","updated_at":"2026-09-05T07:14:06.687Z"}},{"listing_type":"product","name":"Ochre Bio","slug":"ochre-bio-product","tagline":"RNA therapeutics company developing medicines to end the need for liver transplants using human liver data, AI discovery, and in-house RNA manufacturing.","description":"Ochre Bio is developing RNA therapies for chronic liver diseases with significant fibrosis, aiming to eliminate the need for liver transplants for the 1.5 million people who die of liver disease globally each year. The company operates three integrated platforms: a Human Discovery Platform combining proprietary gene perturbation atlases with patient disease atlases to identify drug targets; a Human Validation Platform using perfused livers, diseased tissue slices, and primary cells with AI; and an in-house RNA Platform that shortens R&D cycle times from years to weeks. Teams are based in Oxford, Taipei, and New York City.\n\nOchre Bio is a product of Ochre Bio.","url":"https://www.ochre-bio.com/","is_stealth":false,"normalized_domain":"ochre-bio.com","normalized_url_key":"ochre-bio.com","parent_slug":"ochre-bio","parent":{"slug":"ochre-bio","name":"Ochre Bio","listing_type":"company","profile_url":"/companies/ochre-bio"},"type_data":{"product_kind":"other","pricing_model":"enterprise","free_tier":false,"open_source":false,"use_cases":["Liver disease treatment","Drug target identification","RNA drug development","Gene therapy","Pharma partnerships"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.ochre-bio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.ochre-bio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Drug Discovery","Healthcare","RNA Therapeutics","AI","Therapeutics","Genomics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:11:41.244Z","added_via":"web","geo":{"keywords":["Ochre Bio","Ochre Bio","Biotech","Drug Discovery","Healthcare","RNA Therapeutics","AI","Therapeutics","Genomics"],"canonical_facts":["Product of Ochre Bio"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:11:41.244Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"genomics","name":"Genomics","note":null,"profile_url":"/categories/genomics"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"rna-therapeutics","name":"RNA Therapeutics","note":null,"profile_url":"/categories/rna-therapeutics"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:11:41.244Z","updated_at":"2026-09-05T07:11:41.244Z"}},{"listing_type":"product","name":"Nephrogen","slug":"nephrogen-product","tagline":"AI and high-throughput in vivo screening platform (NeFIND) that engineers AAV delivery vehicles 10–100x more efficient for kidney and pancreatic gene therapy.","description":"Nephrogen is a Stanford biotech spinout developing curative genetic medicines for kidney and pancreatic diseases using their NeFIND platform, which combines AI and high-throughput in vivo screening to design and validate novel AAV delivery vehicles with tissue-specific tropism. The identified AAV vectors are 10–100x more efficient, cheaper, and less immunogenic than existing options, enabling gene therapy for diseases affecting 1 in 7 Americans that currently have no approved gene-based treatments. The company is co-founded by a Stanford computational biologist and a Stanford nephrologist.\n\nNephrogen is a product of Nephrogen.","url":"https://www.nephrogenbiotech.com/","is_stealth":false,"normalized_domain":"nephrogenbiotech.com","normalized_url_key":"nephrogenbiotech.com","parent_slug":"nephrogen","parent":{"slug":"nephrogen","name":"Nephrogen","listing_type":"company","profile_url":"/companies/nephrogen"},"type_data":{"product_kind":"other","pricing_model":"enterprise","free_tier":false,"open_source":false,"use_cases":["Gene therapy delivery","Kidney disease treatment","Pancreatic disease treatment","AAV vector design","Pharma licensing"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.nephrogenbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.nephrogenbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Gene Therapy","Healthcare","AI","Drug Discovery","Therapeutics","CRISPR"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:11:29.593Z","added_via":"web","geo":{"keywords":["Nephrogen","Nephrogen","Biotech","Gene Therapy","Healthcare","AI","Drug Discovery","Therapeutics","CRISPR"],"canonical_facts":["Product of Nephrogen"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:11:29.593Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/categories/crispr"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:11:29.593Z","updated_at":"2026-09-05T07:11:29.593Z"}},{"listing_type":"product","name":"OpenBiome Foundation","slug":"openbiome-foundation","tagline":"Nonprofit foundation that accelerates microbiome science and expands patient access to microbiome therapies including FMT.","description":"The OpenBiome Foundation works to expand patient access to microbiome therapies and drive scientific discoveries in the field. It originally pioneered safe access to fecal microbiota transplantation (FMT) for recurrent C. difficile infections and now provides targeted investments, strategic collaborations, and open-access resources to equip clinicians, scientists, and healthcare systems. Goals by 2030 include closing treatment gaps for C. diff and enabling life-changing microbiome therapies more broadly.\n\nOpenBiome Foundation is a product of OpenBiome.","url":"https://openbiome.org/","is_stealth":false,"normalized_domain":"openbiome.org","normalized_url_key":"openbiome.org","parent_slug":"openbiome","parent":{"slug":"openbiome","name":"OpenBiome","listing_type":"company","profile_url":"/companies/openbiome"},"type_data":{"product_kind":"other","platforms":["web"],"use_cases":["fecal microbiota transplantation access","microbiome research funding","C. diff treatment","open-access scientific resources for clinicians"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://openbiome.org/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://openbiome.org/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Nonprofit","Therapeutics","Research"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:09:08.177Z","added_via":"web","geo":{"keywords":["OpenBiome Foundation","OpenBiome","Healthcare","Nonprofit","Therapeutics","Research"],"canonical_facts":["Product of OpenBiome"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:09:08.177Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"nonprofit","name":"Nonprofit","note":null,"profile_url":"/categories/nonprofit"},{"kind":"product_category","slug":"research","name":"Research","note":null,"profile_url":"/categories/research"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:09:08.177Z","updated_at":"2026-09-05T07:09:08.177Z"}},{"listing_type":"product","name":"Kernal mRNA Platform","slug":"kernal-mrna-platform","tagline":"An AI-guided mRNA therapeutics platform that selectively programs target cells in vivo for cancer and autoimmune disease treatment.","description":"Kernal Biologics is developing an mRNA 2.0 therapeutics platform that delivers mRNA-LNP constructs to specific target cells in vivo, enabling scalable in vivo CAR-T programming without costly ex vivo manufacturing. The platform uses AI-guided design to ensure selective translation in specific tissues, achieving over 90% delivery efficiency with T-cell-targeted LNPs. The lead program KR-402 targets B-cell depletion for cancer and autoimmune diseases.\n\nKernal mRNA Platform is a product of Kernal Biologics.","url":"https://www.kernalbio.com/","is_stealth":false,"normalized_domain":"kernalbio.com","normalized_url_key":"kernalbio.com","parent_slug":"kernal-biologics","parent":{"slug":"kernal-biologics","name":"Kernal Biologics","listing_type":"company","profile_url":"/companies/kernal-biologics"},"type_data":{"product_kind":"other","free_tier":false,"open_source":false,"use_cases":["in vivo CAR-T therapy","cancer treatment","autoimmune disease treatment","mRNA targeted delivery"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.kernalbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.kernalbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Therapeutics","AI","Genomics","Artificial Intelligence"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:06:27.666Z","added_via":"web","geo":{"keywords":["Kernal mRNA Platform","Kernal Biologics","Biotech","Healthcare","Therapeutics","AI","Genomics","Artificial Intelligence"],"canonical_facts":["Product of Kernal Biologics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:06:27.666Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/categories/artificial-intelligence"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"genomics","name":"Genomics","note":null,"profile_url":"/categories/genomics"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:06:27.666Z","updated_at":"2026-09-05T07:06:27.666Z"}},{"listing_type":"product","name":"Altay Therapeutics","slug":"altay-therapeutics-service","tagline":"Small molecule drug discovery platform unlocking transcription factors to treat FSHD, inflammatory diseases, and oncology.","description":"Altay Therapeutics has developed a platform that identifies novel allosteric sites on transcription factors — historically considered undruggable — to design highly selective small molecule inhibitors. Lead programs include DX5057, the first oral DUX4 inhibitor for facioscapulohumeral muscular dystrophy (FSHD) with preclinical efficacy comparable to leading IV gene-targeting therapies, and a best-in-class STAT3 inhibitor with nanomolar potency for inflammatory diseases and oncology. A third undisclosed program targets sarcomas and prostate cancer.\n\nAltay Therapeutics is a product of Altay Therapeutics.","url":"https://www.altaytherapeutics.com/","is_stealth":false,"normalized_domain":"altaytherapeutics.com","normalized_url_key":"altaytherapeutics.com","parent_slug":"altay-therapeutics","parent":{"slug":"altay-therapeutics","name":"Altay Therapeutics","listing_type":"company","profile_url":"/companies/altay-therapeutics"},"type_data":{"product_kind":"service","open_source":false,"use_cases":["Transcription factor drug discovery","FSHD treatment development","Inflammatory disease therapeutics","Oncology drug candidates"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.altaytherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.altaytherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Drug Discovery","Healthcare","Therapeutics","AI-powered Drug Discovery"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:56:22.473Z","added_via":"web","geo":{"keywords":["Altay Therapeutics","Altay Therapeutics","Biotech","Drug Discovery","Healthcare","Therapeutics","AI-powered Drug Discovery"],"canonical_facts":["Product of Altay Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:56:22.473Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/categories/ai-powered-drug-discovery"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:56:22.473Z","updated_at":"2026-09-05T06:56:22.473Z"}},{"listing_type":"product","name":"Algen Biotechnologies","slug":"algen-biotechnologies-service","tagline":"CRISPR and AI drug discovery platform that identifies disease-driving RNA signaling pathways at single-cell resolution.","description":"Algen Biotechnologies uses AlgenCRISPR, a proprietary next-generation CRISPR gene modulation system, paired with AlgenBrain, an AI foundation model trained on billions of real-time gene expression changes across disease progression. The combined platform enables single-cell gene modulation at industrial scale to identify disease-driving RNA signaling pathways and discover first-in-class drugs for conditions with high unmet needs. Founded on research from Nobel Laureate Jennifer Doudna's lab.\n\nAlgen Biotechnologies is a product of Algen Biotechnologies.","url":"https://www.algenbio.com/","is_stealth":false,"normalized_domain":"algenbio.com","normalized_url_key":"algenbio.com","parent_slug":"algen-biotechnologies","parent":{"slug":"algen-biotechnologies","name":"Algen Biotechnologies","listing_type":"company","profile_url":"/companies/algen-biotechnologies"},"type_data":{"product_kind":"service","open_source":false,"use_cases":["Drug target discovery","RNA signaling network analysis","Single-cell gene modulation research","Identifying disease-driving pathways"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.algenbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.algenbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Drug Discovery","AI","CRISPR","Healthcare","Drug Discovery and Delivery","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:56:21.511Z","added_via":"web","geo":{"keywords":["Algen Biotechnologies","Algen Biotechnologies","Biotech","Drug Discovery","AI","CRISPR","Healthcare","Drug Discovery and Delivery","Therapeutics"],"canonical_facts":["Product of Algen Biotechnologies"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:56:21.511Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/categories/crispr"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:56:21.511Z","updated_at":"2026-09-05T06:56:21.511Z"}},{"listing_type":"product","name":"Abalone Bio","slug":"abalone-bio-service","tagline":"Drug discovery platform using functional antibody selection at 100M-antibody scale to create target-activating drugs for GPCRs.","description":"Abalone Bio's FAST (Functional Antibody Selection Technology) platform measures the functional activity of hundreds of millions of antibodies per experiment using engineered yeast cells that link cell survival to antibody activity against a target — 100x more throughput than others. This generates large proprietary activity datasets that enable machine learning to design activating antibodies for GPCRs, the hardest target class. The company focuses on diseases where inhibition-only approaches have failed and collaborates with top drug companies.\n\nAbalone Bio is a product of Abalone Bio.","url":"https://www.abalonebio.com/","is_stealth":false,"normalized_domain":"abalonebio.com","normalized_url_key":"abalonebio.com","parent_slug":"abalone-bio","parent":{"slug":"abalone-bio","name":"Abalone Bio","listing_type":"company","profile_url":"/companies/abalone-bio"},"type_data":{"product_kind":"service","open_source":false,"use_cases":["Discovering activating antibodies for GPCRs","Drug discovery partnerships for challenging targets","AI-enabled antibody design","Treating obesity and metabolic diseases"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.abalonebio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.abalonebio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Drug Discovery","AI","Healthcare","Machine Learning","Drug Discovery and Delivery","Synthetic Biology","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:56:06.734Z","added_via":"web","geo":{"keywords":["Abalone Bio","Abalone Bio","Biotech","Drug Discovery","AI","Healthcare","Machine Learning","Drug Discovery and Delivery","Synthetic Biology","Therapeutics"],"canonical_facts":["Product of Abalone Bio"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:56:06.734Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"machine-learning","name":"Machine Learning","note":null,"profile_url":"/categories/machine-learning"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:56:06.734Z","updated_at":"2026-09-05T06:56:06.734Z"}},{"listing_type":"product","name":"Yemaachi Biotech","slug":"yemaachi-biotech","tagline":"Africa-led cancer innovation company leveraging underrepresented genomic data to advance precision oncology globally.","description":"Yemaachi Biotech pioneers clinical genomic research across Africa to advance precision oncology. The company collects and sequences biological samples from the most genetically diverse population on earth to build a first-of-its-kind cancer knowledgebase on African people. It partners with public, private, and non-profit organizations globally to diversify cancer diagnostics and therapeutics. Offices are in Ghana, USA, and Kenya.\n\nYemaachi Biotech is a product of Yemaachi Biotechnology.","url":"https://www.yemaachi.com/","is_stealth":false,"normalized_domain":"yemaachi.com","normalized_url_key":"yemaachi.com","parent_slug":"yemaachi-biotechnology","parent":{"slug":"yemaachi-biotechnology","name":"Yemaachi Biotechnology","listing_type":"company","profile_url":"/companies/yemaachi-biotechnology"},"type_data":{"product_kind":"service","open_source":false,"use_cases":["Cancer genomics research","Precision oncology diagnostics","Optimizing diagnostic tests for African populations","Drug discovery partnerships"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.yemaachi.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.yemaachi.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Oncology","Genomics","Diagnostics","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:55:50.534Z","added_via":"web","geo":{"keywords":["Yemaachi Biotech","Yemaachi Biotechnology","Biotech","Healthcare","Oncology","Genomics","Diagnostics","Therapeutics"],"canonical_facts":["Product of Yemaachi Biotechnology"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:55:50.534Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/categories/diagnostics"},{"kind":"product_category","slug":"genomics","name":"Genomics","note":null,"profile_url":"/categories/genomics"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:55:50.534Z","updated_at":"2026-09-05T06:55:50.534Z"}},{"listing_type":"product","name":"LiliumX","slug":"liliumx","tagline":"Proprietary bispecific ADC discovery platform using synthetic protein biology, high-throughput screening, and AI to develop next-generation cancer therapeutics.","description":"LiliumX is Valink Therapeutics' proprietary drug discovery platform built on three pillars: synthetic protein biology, high-throughput functional screening, and AI. The platform enables broad exploration of bispecific antibody-drug conjugates (BsADCs) using a V-Gate approach that gates therapeutic binding based on continuous levels of two molecular targets on tumor cells, enabling more selective and potent targeting with fewer effects on healthy tissue. Valink is currently advancing three oncology-focused programs using the platform.\n\nLiliumX is a product of Valink Therapeutics.","url":"https://www.valinktx.com/","is_stealth":false,"normalized_domain":"valinktx.com","normalized_url_key":"valinktx.com","parent_slug":"valink-therapeutics","parent":{"slug":"valink-therapeutics","name":"Valink Therapeutics","listing_type":"company","profile_url":"/companies/valink-therapeutics"},"type_data":{"product_kind":"other","use_cases":["Bispecific ADC drug discovery","Solid tumor therapy development","Overcoming cancer drug resistance"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.valinktx.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.valinktx.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Drug Discovery","AI","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:55:08.476Z","added_via":"web","geo":{"keywords":["LiliumX","Valink Therapeutics","Healthcare","Biotech","Drug Discovery","AI","Therapeutics"],"canonical_facts":["Product of Valink Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:55:08.476Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:55:08.476Z","updated_at":"2026-09-05T06:55:08.476Z"}},{"listing_type":"product","name":"Gilgamesh Pharmaceuticals","slug":"gilgamesh-pharmaceuticals-product","tagline":"Clinical-stage biotech developing novel precision psychiatric medicines targeting brain plasticity mechanisms for depression, anxiety, and addiction.","description":"Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company developing novel chemical entities (NCEs) that engage brain plasticity mechanisms to treat psychiatric conditions including depression, anxiety, addiction, and schizophrenia. Its pipeline includes Bretisilocin (GM-2505, acquired by AbbVie), Blixeprodil (GM-1020, an oral NMDAR antagonist), Neuroplastogens (in partnership with AbbVie), GM-3009 (ibogaine analogs for opioid use disorder), and an M1/M4 agonist for schizophrenia. Discovery is powered by a platform combining medicinal chemistry with AI-driven translational methods.\n\nGilgamesh Pharmaceuticals is a product of Gilgamesh Pharmaceuticals.","url":"https://www.gilgameshpharmaceutical.com/","is_stealth":false,"normalized_domain":"gilgameshpharmaceutical.com","normalized_url_key":"gilgameshpharmaceutical.com","parent_slug":"gilgamesh-pharmaceuticals","parent":{"slug":"gilgamesh-pharmaceuticals","name":"Gilgamesh Pharmaceuticals","listing_type":"company","profile_url":"/companies/gilgamesh-pharmaceuticals"},"type_data":{"product_kind":"other","free_tier":false,"open_source":false,"use_cases":["depression treatment","anxiety treatment","opioid use disorder treatment","schizophrenia treatment","PTSD treatment"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.gilgameshpharmaceutical.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.gilgameshpharmaceutical.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Drug Discovery","Mental Health","Drug Discovery and Delivery","Therapeutics","Psychedelics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:53:26.403Z","added_via":"web","geo":{"keywords":["Gilgamesh Pharmaceuticals","Gilgamesh Pharmaceuticals","Biotech","Healthcare","Drug Discovery","Mental Health","Drug Discovery and Delivery","Therapeutics","Psychedelics"],"canonical_facts":["Product of Gilgamesh Pharmaceuticals"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:53:26.403Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"mental-health","name":"Mental Health","note":null,"profile_url":"/categories/mental-health"},{"kind":"product_category","slug":"psychedelics","name":"Psychedelics","note":null,"profile_url":"/categories/psychedelics"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:53:26.403Z","updated_at":"2026-09-05T06:53:26.403Z"}},{"listing_type":"product","name":"Equator Therapeutics","slug":"equator-therapeutics-product","tagline":"Developing a first-in-class drug that pharmacologically activates thermogenesis to treat obesity and metabolic disorders.","description":"Equator Therapeutics is a clinical-stage biotech company developing a novel drug that targets mitochondria to stimulate natural heat production (thermogenesis) as a treatment for obesity and metabolic disorders. The company uses proprietary high-throughput assays to identify selective and safe thermogenic compounds by directly measuring the electrical currents in mitochondria that generate heat. Its long-term pipeline also includes programs targeting other mitochondrial mechanisms.\n\nEquator Therapeutics is a product of Equator Therapeutics.","url":"https://equatortherapeutics.com/","is_stealth":false,"normalized_domain":"equatortherapeutics.com","normalized_url_key":"equatortherapeutics.com","parent_slug":"equator-therapeutics","parent":{"slug":"equator-therapeutics","name":"Equator Therapeutics","listing_type":"company","profile_url":"/companies/equator-therapeutics"},"type_data":{"product_kind":"other","free_tier":false,"open_source":false,"use_cases":["obesity treatment","metabolic disorder treatment","thermogenesis-based weight loss"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://equatortherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://equatortherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Therapeutics","Drug Discovery"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:52:47.311Z","added_via":"web","geo":{"keywords":["Equator Therapeutics","Equator Therapeutics","Biotech","Healthcare","Therapeutics","Drug Discovery"],"canonical_facts":["Product of Equator Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:52:47.311Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:52:47.311Z","updated_at":"2026-09-05T06:52:47.311Z"}},{"listing_type":"product","name":"Serna Bio","slug":"serna-bio-product","tagline":"AI-driven platform that identifies and optimizes small molecules targeting RNA to accelerate novel drug discovery.","description":"Serna Bio uses AI to identify and optimize small molecules that interact with RNA targets, enabling drug discovery for diseases difficult to treat with traditional modalities. The company focuses on RNA-targeted therapeutics by combining AI-powered workflows with small molecule chemistry. Their approach aims to unlock disease biology intractable to protein-targeting drugs.\n\nSerna Bio is a product of Serna Bio.","url":"https://www.serna.bio/","is_stealth":false,"normalized_domain":"serna.bio","normalized_url_key":"serna.bio","parent_slug":"serna-bio","parent":{"slug":"serna-bio","name":"Serna Bio","listing_type":"company","profile_url":"/companies/serna-bio"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["RNA-targeted drug discovery","Small molecule optimization"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.serna.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.serna.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Drug Discovery","AI","Healthcare","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:51:24.794Z","added_via":"web","geo":{"keywords":["Serna Bio","Serna Bio","Biotech","Drug Discovery","AI","Healthcare","Therapeutics"],"canonical_facts":["Product of Serna Bio"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:51:24.794Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:51:24.794Z","updated_at":"2026-09-05T06:51:24.794Z"}},{"listing_type":"product","name":"SFA-002","slug":"sfa-002","tagline":"Oral deuterated short-chain fatty acid that resets immunity through the gut-immune axis to treat plaque psoriasis and autoimmune diseases.","description":"SFA-002 is an investigational oral drug developed by SFA Therapeutics that targets the gut-immune axis with once-daily dosing to reduce systemic inflammation. Phase 1b data from 28 patients with mild-to-severe plaque psoriasis showed significant response rates across all primary endpoints with no treatment-emergent adverse events. The proprietary deuteration platform generates patentable new chemical entities from naturally occurring short-chain fatty acids. A randomized, double-blind, placebo-controlled study in 120 patients is ongoing.\n\nSFA-002 is a product of SFA Therapeutics.","url":"https://sfatherapeutics.com/","is_stealth":false,"normalized_domain":"sfatherapeutics.com","normalized_url_key":"sfatherapeutics.com","parent_slug":"sfa-therapeutics-inc","parent":{"slug":"sfa-therapeutics-inc","name":"SFA Therapeutics","listing_type":"company","profile_url":"/companies/sfa-therapeutics-inc"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Plaque psoriasis treatment","Autoimmune disease treatment"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://sfatherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://sfatherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Therapeutics","Healthcare","Immunology","AI-powered Drug Discovery","Anti-Aging","Health & Wellness","Biotechnology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:51:24.690Z","added_via":"web","geo":{"keywords":["SFA-002","SFA Therapeutics","Biotech","Therapeutics","Healthcare","Immunology","AI-powered Drug Discovery","Anti-Aging","Health & Wellness","Biotechnology"],"canonical_facts":["Product of SFA Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:51:24.690Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/categories/ai-powered-drug-discovery"},{"kind":"product_category","slug":"anti-aging","name":"Anti-Aging","note":null,"profile_url":"/categories/anti-aging"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/categories/biotechnology"},{"kind":"product_category","slug":"health-and-wellness","name":"Health & Wellness","note":null,"profile_url":"/categories/health-and-wellness"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"immunology","name":"Immunology","note":null,"profile_url":"/categories/immunology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:51:24.690Z","updated_at":"2026-09-05T06:51:24.690Z"}},{"listing_type":"product","name":"Sensible Biotechnologies","slug":"sensible-biotechnologies-product","tagline":"Cell-based mRNA design and manufacturing platform producing pure, low-immunogenicity mRNA for next-generation therapeutics.","description":"Sensible Biotechnologies is building the first cell-based mRNA therapeutics platform, using living cells as factories to produce highly stable mRNA with low immunogenicity that overcomes the limitations of conventional synthetic mRNA. Their approach enables scalable, cost-effective manufacturing of mRNA for therapeutic applications. The company targets the manufacturing challenges currently limiting the broader potential of mRNA medicines and positions their cell-based platform as enabling a new era of design-based biology.\n\nSensible Biotechnologies is a product of Sensible Biotechnologies.","url":"https://www.sensible.bio/","is_stealth":false,"normalized_domain":"sensible.bio","normalized_url_key":"sensible.bio","parent_slug":"sensible-biotechnologies","parent":{"slug":"sensible-biotechnologies","name":"Sensible Biotechnologies","listing_type":"company","profile_url":"/companies/sensible-biotechnologies"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["mRNA therapeutics manufacturing","gene therapy","biomanufacturing"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.sensible.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.sensible.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Therapeutics","Manufacturing","Healthcare","Synthetic Biology","Biotechnology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:51:13.015Z","added_via":"web","geo":{"keywords":["Sensible Biotechnologies","Sensible Biotechnologies","Biotech","Therapeutics","Manufacturing","Healthcare","Synthetic Biology","Biotechnology"],"canonical_facts":["Product of Sensible Biotechnologies"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:51:13.015Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/categories/biotechnology"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"manufacturing","name":"Manufacturing","note":null,"profile_url":"/categories/manufacturing"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:51:13.015Z","updated_at":"2026-09-05T06:51:13.015Z"}},{"listing_type":"product","name":"SafeBeat Rx","slug":"safebeat-rx","tagline":"Clinician-focused platform for remote cardiac therapeutic monitoring using FDA-cleared devices and AI-powered ECG analysis from a smartphone.","description":"SafeBeat Rx is a clinician platform that extends cardiac care beyond diagnostics to guide remote therapeutic monitoring using third-party FDA-cleared cardiac monitoring devices including mobile ECG, mobile cardiac telemetry, and implantable cardiac monitors. Proprietary AI algorithms power ECG interpretation and treatment management, with explainable AI and patient-specific care workflows designed to reduce alert fatigue. The software is built for use from a mobile phone and is designed by clinician founders including a cardiologist specializing in heart rhythm disorders. The company also licenses its AI software to power third-party products.\n\nSafeBeat Rx is a product of SafeBeat.","url":"https://safebeat.com/","is_stealth":false,"normalized_domain":"safebeat.com","normalized_url_key":"safebeat.com","parent_slug":"safebeat","parent":{"slug":"safebeat","name":"SafeBeat","listing_type":"company","profile_url":"/companies/safebeat"},"type_data":{"product_kind":"saas","platforms":["ios","android","web"],"free_tier":false,"open_source":false,"use_cases":["remote cardiac monitoring","ECG analysis","arrhythmia management","cardiac therapeutic guidance","clinical decision support"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://safebeat.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://safebeat.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Digital Health","AI","Medical Devices","AI-Enhanced Learning","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:51:05.889Z","added_via":"web","geo":{"keywords":["SafeBeat Rx","SafeBeat","Healthcare","Digital Health","AI","Medical Devices","AI-Enhanced Learning","Therapeutics"],"canonical_facts":["Product of SafeBeat"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:51:05.889Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"ai-enhanced-learning","name":"AI-Enhanced Learning","note":null,"profile_url":"/categories/ai-enhanced-learning"},{"kind":"product_category","slug":"digital-health","name":"Digital Health","note":null,"profile_url":"/categories/digital-health"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/categories/medical-devices"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:51:05.889Z","updated_at":"2026-09-05T06:51:05.889Z"}},{"listing_type":"product","name":"Promakhos Therapeutics","slug":"promakhos-therapeutics-product","tagline":"Drug development platform for non-immunosuppressive therapies that restore natural immune function in inflammatory diseases.","description":"Promakhos Therapeutics is a Boston-based biotech developing medicines for chronic inflammatory diseases including Crohn's disease, Type 1 Diabetes, and Multiple Sclerosis. Unlike standard immunosuppressive treatments, their approach uses bacterial molecules to restore the body's innate ability to control inflammation and heal rather than suppressing the immune system. Their lead oral drug candidate for Crohn's disease has received a Phase 1 SBIR grant of $271,865 from NIDDK, and the company won the Harvard President's Innovation Challenge.\n\nPromakhos Therapeutics is a product of Promakhos Therapeutics.","url":"https://www.promakhos.com/","is_stealth":false,"normalized_domain":"promakhos.com","normalized_url_key":"promakhos.com","parent_slug":"promakhos-therapeutics","parent":{"slug":"promakhos-therapeutics","name":"Promakhos Therapeutics","listing_type":"company","profile_url":"/companies/promakhos-therapeutics"},"type_data":{"product_kind":"other","open_source":false,"launched_year":2021,"use_cases":["Crohn's disease treatment","inflammatory disease therapy","immune system restoration"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.promakhos.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.promakhos.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Therapeutics","Healthcare"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:50:20.499Z","added_via":"web","geo":{"keywords":["Promakhos Therapeutics","Promakhos Therapeutics","Biotech","Therapeutics","Healthcare"],"canonical_facts":["Product of Promakhos Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:50:20.499Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:50:20.499Z","updated_at":"2026-09-05T06:50:20.499Z"}},{"listing_type":"product","name":"Humane Genomics","slug":"humane-genomics-product","tagline":"Platform for engineering oncolytic viruses that precisely target and destroy cancer cells with high selectivity.","description":"Humane Genomics engineers cancer-killing viruses with a two-factor authentication approach—selective infection and selective replication—achieving an on-target to off-target kill ratio greater than 1000. The company is developing its first indication in pediatric liver cancer (hepatoblastoma) in partnership with Texas Children's Hospital and has partnered with Genezen for cGMP manufacturing of its lead oncolytic virus candidate.\n\nHumane Genomics is a product of Humane Genomics.","url":"https://humanegenomics.com/","is_stealth":false,"normalized_domain":"humanegenomics.com","normalized_url_key":"humanegenomics.com","parent_slug":"humane-genomics","parent":{"slug":"humane-genomics","name":"Humane Genomics","listing_type":"company","profile_url":"/companies/humane-genomics"},"type_data":{"product_kind":"other","free_tier":false,"open_source":false,"use_cases":["Cancer treatment via oncolytic virotherapy","Pediatric liver cancer therapy"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://humanegenomics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://humanegenomics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Therapeutics","Synthetic Biology","Healthcare","Hard Tech"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:41:21.236Z","added_via":"web","geo":{"keywords":["Humane Genomics","Humane Genomics","Biotech","Therapeutics","Synthetic Biology","Healthcare","Hard Tech"],"canonical_facts":["Product of Humane Genomics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:41:21.236Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"hard-tech","name":"Hard Tech","note":null,"profile_url":"/categories/hard-tech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:41:21.236Z","updated_at":"2026-09-05T06:41:21.236Z"}},{"listing_type":"product","name":"Entelexo","slug":"entelexo","tagline":"Proprietary exosome engineering platform developing multi-target therapeutics for autoimmune diseases including rheumatoid arthritis, Crohn's, and psoriasis.","description":"Entelexo is developing a novel class of engineered exosome-based therapeutics for autoimmune diseases through a proprietary rational engineering platform. Their exosomes are designed to communicate with multiple specific diseased cell types simultaneously, addressing the multi-pathway complexity of conditions like Rheumatoid Arthritis, Crohn's Disease, and Psoriasis that existing single-target therapies cannot fully treat. The company has an initial pipeline of product candidates de-risked with human cell immunoassays and is preparing for pre-IND FDA studies.\n\nEntelexo is a product of Entelexo Biotherapeutics.","url":"https://www.entelexo.com/","is_stealth":false,"normalized_domain":"entelexo.com","normalized_url_key":"entelexo.com","parent_slug":"entelexo-biotherapeutics","parent":{"slug":"entelexo-biotherapeutics","name":"Entelexo Biotherapeutics","listing_type":"company","profile_url":"/companies/entelexo-biotherapeutics"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["autoimmune disease treatment","rheumatoid arthritis therapy","Crohn's disease therapy","psoriasis therapy"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.entelexo.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.entelexo.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:39:28.888Z","added_via":"web","geo":{"keywords":["Entelexo","Entelexo Biotherapeutics","Biotech","Healthcare","Therapeutics"],"canonical_facts":["Product of Entelexo Biotherapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:39:28.888Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:39:28.888Z","updated_at":"2026-09-05T06:39:28.888Z"}},{"listing_type":"product","name":"Nuntius Therapeutics","slug":"nuntius-therapeutics-product","tagline":"Biotech platform developing programmable nanocarrier delivery systems and engineered mRNA therapeutics targeting cancer, lung, and neurodegenerative diseases.","description":"Nuntius Therapeutics is a biotech company building cell-specific genetic medicine technology through three capability pillars: programmable non-immunogenic nanocarriers that can target tissues beyond the liver; ML models that predict carrier quality and performance across millions of candidates; and engineered mRNA with superior protein expression compared to clinically used mRNA. The company is advancing a drug pipeline targeting cancer, lung diseases, and neurodegenerative diseases, with operations in Delaware, USA and London, UK.\n\nNuntius Therapeutics is a product of Nuntius Therapeutics.","url":"https://nuntiustx.com/","is_stealth":false,"normalized_domain":"nuntiustx.com","normalized_url_key":"nuntiustx.com","parent_slug":"nuntius-therapeutics","parent":{"slug":"nuntius-therapeutics","name":"Nuntius Therapeutics","listing_type":"company","profile_url":"/companies/nuntius-therapeutics"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Cancer therapy development","Lung disease treatment","Neurodegenerative disease treatment","mRNA drug delivery"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://nuntiustx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://nuntiustx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Gene Therapy","Drug Discovery","Healthcare","Therapeutics","Nanomedicine"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:38:29.336Z","added_via":"web","geo":{"keywords":["Nuntius Therapeutics","Nuntius Therapeutics","Biotech","Gene Therapy","Drug Discovery","Healthcare","Therapeutics","Nanomedicine"],"canonical_facts":["Product of Nuntius Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:38:29.336Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/categories/nanomedicine"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:38:29.336Z","updated_at":"2026-09-05T06:38:29.336Z"}},{"listing_type":"product","name":"CysTyr Conjugation Platform","slug":"cystyr-conjugation-platform","tagline":"Protein conjugation platform enabling multi-payload antibody-drug conjugates via a novel cystine-tyrosine bond for next-generation cancer therapeutics.","description":"Catena Biosciences' CysTyr Conjugation Platform enables attachment of multiple payloads of any size and complexity to a single antibody through a novel C-Y Bond between naturally occurring amino acids cystine and tyrosine. It supports flexible drug-to-antibody ratios and precise conjugation site control, overcoming limitations of traditional ADCs restricted to single small-molecule payloads with unstable maleimide bonds. With an initial focus on solid tumors with high unmet medical need, the resulting Multi-Payload Conjugates show preclinical superiority to current standards of care.\n\nCysTyr Conjugation Platform is a product of Catena Biosciences.","url":"https://catenabio.com/","is_stealth":false,"normalized_domain":"catenabio.com","normalized_url_key":"catenabio.com","parent_slug":"catena-biosciences","parent":{"slug":"catena-biosciences","name":"Catena Biosciences","listing_type":"company","profile_url":"/companies/catena-biosciences"},"type_data":{"product_kind":"other","free_tier":false,"open_source":false,"use_cases":["Antibody-drug conjugate development","Cancer therapy","Multi-payload therapeutic design","Oncology drug discovery"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://catenabio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://catenabio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Drug Discovery","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:34:36.781Z","added_via":"web","geo":{"keywords":["CysTyr Conjugation Platform","Catena Biosciences","Biotech","Healthcare","Drug Discovery","Therapeutics"],"canonical_facts":["Product of Catena Biosciences"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:34:36.781Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:34:36.781Z","updated_at":"2026-09-05T06:34:36.781Z"}},{"listing_type":"product","name":"Biodock","slug":"biodock-platform","tagline":"No-code cloud AI platform for biological image analysis that trains and runs custom deep learning models on microscopy images.","description":"Biodock is an end-to-end AI platform for biological image analysis enabling scientists to train custom deep learning models and run them on large datasets without writing code. Features include AI-assisted labeling, interactive AI Click annotation, automated labeling bootstrapping, and one-click execution on distributed clusters providing up to 3000x acceleration. Results include object-level metrics (area, intensity, colocalization), customizable plots, and population comparisons. It supports multi-channel 2D images with up to 100 channels, integrates with AWS S3, Google Drive, Dropbox, Box, and OneDrive, and is SOC 2 Type II certified.\n\nBiodock is a product of Biodock.","url":"https://www.biodock.ai/","is_stealth":false,"normalized_domain":"biodock.ai","normalized_url_key":"biodock.ai","parent_slug":"biodock","parent":{"slug":"biodock","name":"Biodock","listing_type":"company","profile_url":"/companies/biodock"},"type_data":{"product_kind":"saas","pricing_model":"subscription","platforms":["web"],"open_source":false,"use_cases":["Microscopy image analysis","Cell detection and counting","Tissue region segmentation","Fluorescence image quantification","Drug discovery image analysis","Scientific collaboration on image data"],"integrations":["AWS S3","Google Drive","Dropbox","Box","OneDrive"]},"logo":null,"links":[],"entry_points":[{"kind":"demo","url":"https://www.biodock.ai/","audience":"human","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"demo","url":"https://www.biodock.ai/","audience":"human","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","AI","SaaS","Biotech","Developer Tools","Therapeutics","Deep Learning"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:33:45.538Z","added_via":"web","geo":{"keywords":["Biodock","Biodock","Healthcare","AI","SaaS","Biotech","Developer Tools","Therapeutics","Deep Learning"],"canonical_facts":["Product of Biodock"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:33:45.538Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"deep-learning","name":"Deep Learning","note":null,"profile_url":"/categories/deep-learning"},{"kind":"product_category","slug":"developer-tools","name":"Developer Tools","note":null,"profile_url":"/categories/developer-tools"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"saas","name":"SaaS","note":null,"profile_url":"/categories/saas"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:33:45.538Z","updated_at":"2026-09-05T06:33:45.538Z"}},{"listing_type":"product","name":"Serinus Biosciences","slug":"serinus-biosciences-service","tagline":"AI platform using systems biology to design combination cancer therapies that overcome treatment resistance.","description":"Serinus Biosciences develops an AI platform primed with systems biology knowledge to identify how cancer cells evolve treatment resistance and design combination therapies to overcome resistance escape routes. The platform aims to deliver safer, more effective combinations that reach patients faster. The company is founded by MIT PhDs and is based in New York. Limited public product detail is available on the website.\n\nSerinus Biosciences is a product of Serinus Biosciences.","url":"https://www.serinus.bio/","is_stealth":false,"normalized_domain":"serinus.bio","normalized_url_key":"serinus.bio","parent_slug":"serinus-biosciences","parent":{"slug":"serinus-biosciences","name":"Serinus Biosciences","listing_type":"company","profile_url":"/companies/serinus-biosciences"},"type_data":{"product_kind":"service","open_source":false,"use_cases":["Cancer combination therapy design","Treatment resistance research","Drug discovery partnerships"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.serinus.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.serinus.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Oncology","AI","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:23:28.324Z","added_via":"web","geo":{"keywords":["Serinus Biosciences","Serinus Biosciences","Biotech","Healthcare","Oncology","AI","Therapeutics"],"canonical_facts":["Product of Serinus Biosciences"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:23:28.324Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:23:28.324Z","updated_at":"2026-09-05T06:23:28.324Z"}},{"listing_type":"product","name":"NistuFe","slug":"nistufe","tagline":"Prescription transdermal skin patch delivering a proprietary iron compound to the bloodstream to treat iron deficiency anemia without GI side effects.","description":"NistuFe (compound KYLK01) is Keylika's lead drug candidate for iron deficiency anemia—a small-molecule iron compound delivered via a self-administrable skin patch that enables direct absorption into the bloodstream, bypassing the GI tract. It aims to combine the efficacy of IV iron with the convenience of oral iron while avoiding the adverse effects of both. The compound has demonstrated proof-of-concept in-vivo in rats with excellent iron uptake and correction of iron deficiency without systemic toxicity. Keylika also has a platform synthesis technology for organometallic drugs across multiple therapeutic areas.\n\nNistuFe is a product of Keylika.","url":"https://www.keylika.com/","is_stealth":false,"normalized_domain":"keylika.com","normalized_url_key":"keylika.com","parent_slug":"keylika","parent":{"slug":"keylika","name":"Keylika","listing_type":"company","profile_url":"/companies/keylika"},"type_data":{"product_kind":"other","free_tier":false,"open_source":false,"use_cases":["Iron deficiency anemia treatment","Home-based iron therapy"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.keylika.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.keylika.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Drug Delivery","Medical Devices","Therapeutics","AI-powered Drug Discovery","Nanotechnology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:22:15.771Z","added_via":"web","geo":{"keywords":["NistuFe","Keylika","Healthcare","Biotech","Drug Delivery","Medical Devices","Therapeutics","AI-powered Drug Discovery","Nanotechnology"],"canonical_facts":["Product of Keylika"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:22:15.771Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/categories/ai-powered-drug-discovery"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/categories/drug-delivery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/categories/medical-devices"},{"kind":"product_category","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/categories/nanotechnology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:22:15.771Z","updated_at":"2026-09-05T06:22:15.771Z"}},{"listing_type":"product","name":"Relevium Medical","slug":"relevium-medical-product","tagline":"Injectable hydrogel platform for long-lasting treatment of chronic pain conditions including knee osteoarthritis.","description":"Relevium Medical is a biopharmaceutical company developing novel hydrogel-based injectable treatments for chronic pain by combining natural biopolymers with pharmacologically active agents. Their lead program targets knee osteoarthritis with a product designed to reduce repeat injections and opioid dependence. The company has received $3.7M in non-dilutive funding and completed preclinical testing demonstrating safety and selective nerve blockade.\n\nRelevium Medical is a product of Relevium Medical.","url":"https://relevium-medical.com/","is_stealth":false,"normalized_domain":"relevium-medical.com","normalized_url_key":"relevium-medical.com","parent_slug":"relevium-medical","parent":{"slug":"relevium-medical","name":"Relevium Medical","listing_type":"company","profile_url":"/companies/relevium-medical"},"type_data":{"product_kind":"other","use_cases":["Chronic pain treatment","Osteoarthritis management","Injectable pain relief"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://relevium-medical.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://relevium-medical.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Drug Discovery","Medical Devices","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:17:36.886Z","added_via":"web","geo":{"keywords":["Relevium Medical","Relevium Medical","Healthcare","Biotech","Drug Discovery","Medical Devices","Therapeutics"],"canonical_facts":["Product of Relevium Medical"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:17:36.886Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/categories/medical-devices"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:17:36.886Z","updated_at":"2026-09-05T06:17:36.886Z"}},{"listing_type":"product","name":"Origami Therapeutics","slug":"origami-therapeutics","tagline":"Small-molecule protein degrader drug discovery platform targeting neurodegenerative diseases including Huntington's and Alzheimer's.","description":"Origami Therapeutics develops novel small-molecule protein degraders that selectively eliminate toxic, disease-causing proteins while sparing normal forms, enabling broad body distribution and ease of manufacture. Proprietary human disease models guide selection of small molecules most likely to achieve clinical success. Primary indications include Huntington's disease, Alzheimer's, Parkinson's, ALS, and Frontotemporal Dementia. Pre-clinical work has demonstrated reduction of toxic mutated protein and suppression of protein-induced toxicities in human models.\n\nOrigami Therapeutics is a product of Origami Therapeutics, Inc..","url":"https://origamitherapeutics.com/","is_stealth":false,"normalized_domain":"origamitherapeutics.com","normalized_url_key":"origamitherapeutics.com","parent_slug":"origami-therapeutics-inc","parent":{"slug":"origami-therapeutics-inc","name":"Origami Therapeutics, Inc.","listing_type":"company","profile_url":"/companies/origami-therapeutics-inc"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Huntington's disease treatment","Neurodegeneration therapy","Protein degradation drug discovery"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://origamitherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://origamitherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Drug discovery","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:16:23.640Z","added_via":"web","geo":{"keywords":["Origami Therapeutics","Origami Therapeutics, Inc.","Healthcare","Biotech","Drug discovery","Therapeutics"],"canonical_facts":["Product of Origami Therapeutics, Inc."]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:16:23.640Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:16:23.640Z","updated_at":"2026-09-05T06:16:23.640Z"}},{"listing_type":"product","name":"Eugit Therapeutics","slug":"eugit-therapeutics-product","tagline":"Tissue-targeting drug delivery platform using T cell receptors to treat inflammatory diseases with precision.","description":"Eugit Therapeutics develops a tissue-targeting drug delivery platform designed to address non-specific drugs that cause toxicity and clinical trial failures in tissue-specific inflammatory diseases. The platform uses T cell receptors to deliver drugs with precision to diseased tissues, enhancing safety and efficacy. Initial focus is on Inflammatory Bowel Disease, with plans to initiate clinical trials within two years. Co-founded by George Church, Professor at Harvard Medical School.\n\nEugit Therapeutics is a product of Eugit Therapeutics.","url":"https://www.eugittx.com/","is_stealth":false,"normalized_domain":"eugittx.com","normalized_url_key":"eugittx.com","parent_slug":"eugit-therapeutics","parent":{"slug":"eugit-therapeutics","name":"Eugit Therapeutics","listing_type":"company","profile_url":"/companies/eugit-therapeutics"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Inflammatory Bowel Disease treatment","tissue-specific drug delivery","reducing drug toxicity"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.eugittx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.eugittx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotechnology","Therapeutics","Synthetic Biology","Cell Therapy","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:11:54.340Z","added_via":"web","geo":{"keywords":["Eugit Therapeutics","Eugit Therapeutics","Healthcare","Biotechnology","Therapeutics","Synthetic Biology","Cell Therapy","Oncology"],"canonical_facts":["Product of Eugit Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:11:54.340Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/categories/biotechnology"},{"kind":"product_category","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/categories/cell-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:11:54.340Z","updated_at":"2026-09-05T06:11:54.340Z"}},{"listing_type":"product","name":"Cisterna Biologics","slug":"cisterna-biologics-service","tagline":"Custom high-purity mRNA and RNA synthesis using proprietary SPECC technology that eliminates dsRNA and other product impurities.","description":"Cisterna Biologics provides custom RNA synthesis and high-purity mRNA products for research, diagnostics, and therapeutics. Their proprietary SPECC (Specific Capture and Cleavage) technology removes product-related impurities — double-stranded RNA, long RNA impurities, and truncated RNA — that standard production methods leave behind, improving efficacy for downstream applications. The company targets gene editing, targeted protein expression, immunology, clinical mRNA therapeutics, and RNA diagnostics.\n\nCisterna Biologics is a product of Cisterna Biologics.","url":"https://www.cisternabx.com/","is_stealth":false,"normalized_domain":"cisternabx.com","normalized_url_key":"cisternabx.com","parent_slug":"cisterna-biologics","parent":{"slug":"cisterna-biologics","name":"Cisterna Biologics","listing_type":"company","profile_url":"/companies/cisterna-biologics"},"type_data":{"product_kind":"service","open_source":false,"launched_year":2022,"use_cases":["mRNA therapeutics research","Gene editing reagents","RNA diagnostics","Clinical RNA production","Immunology research"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.cisternabx.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.cisternabx.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Synthetic Biology","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:06:11.137Z","added_via":"web","geo":{"keywords":["Cisterna Biologics","Cisterna Biologics","Biotech","Healthcare","Synthetic Biology","Therapeutics"],"canonical_facts":["Product of Cisterna Biologics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:06:11.137Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:06:11.137Z","updated_at":"2026-09-05T06:06:11.137Z"}},{"listing_type":"product","name":"DynaChip X1","slug":"dynachip-x1","tagline":"Next-generation microfluidic mass spectrometry sample preparation device that simplifies and accelerates bioanalytical workflows.","description":"The DynaChip X1 by Andson Biotech is a mass spectrometry sample preparation platform that combines microfluidic design with analytical performance. It is designed to remove technical barriers for pharmaceutical companies measuring difficult-to-detect chemicals during drug development and quality control for cell therapies and biologics. The device aims to simplify and accelerate complex MS workflows that drug companies perform thousands of times per day.\n\nDynaChip X1 is a product of Andson Biotech.","url":"http://www.andsonbiotech.com/","is_stealth":false,"normalized_domain":"andsonbiotech.com","normalized_url_key":"andsonbiotech.com","parent_slug":"andson-biotech","parent":{"slug":"andson-biotech","name":"Andson Biotech","listing_type":"company","profile_url":"/companies/andson-biotech"},"type_data":{"product_kind":"hardware","open_source":false,"use_cases":["Drug development analytical testing","Biologic quality control","Cell therapy characterization","Mass spectrometry workflow acceleration"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"http://www.andsonbiotech.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"http://www.andsonbiotech.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Hardware","Drug Discovery","Gene Therapy","Hard Tech","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:59:51.879Z","added_via":"web","geo":{"keywords":["DynaChip X1","Andson Biotech","Biotech","Healthcare","Hardware","Drug Discovery","Gene Therapy","Hard Tech","Therapeutics"],"canonical_facts":["Product of Andson Biotech"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:59:51.879Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"hard-tech","name":"Hard Tech","note":null,"profile_url":"/categories/hard-tech"},{"kind":"product_category","slug":"hardware","name":"Hardware","note":null,"profile_url":"/categories/hardware"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:59:51.879Z","updated_at":"2026-09-05T05:59:51.879Z"}},{"listing_type":"product","name":"Alixia","slug":"alixia-product","tagline":"Biopharma research platform developing tumor ecosystem disruptors that target cancer drug resistance across multiple cell types.","description":"Alixia is a biopharma company developing a portfolio of therapeutic compounds targeting the tumor microenvironment as an ecological system rather than a single mutation. Their research platform integrates biology, biophysics, computational chemistry, and clinical input to identify lead compounds that disrupt metabolic and inflammatory triggers in both cancer and quasi-cancerous cells. Current programs span various stages of preclinical development addressing multiple age-related diseases at the intersection of cancer, aging, and immunity.\n\nAlixia is a product of Alixia.","url":"https://www.alixia.com/","is_stealth":false,"normalized_domain":"alixia.com","normalized_url_key":"alixia.com","parent_slug":"alixia","parent":{"slug":"alixia","name":"Alixia","listing_type":"company","profile_url":"/companies/alixia"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Cancer drug resistance treatment","Tumor microenvironment targeting","Neurodegenerative disease therapy"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.alixia.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.alixia.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Oncology","Drug Discovery","Healthcare","Therapeutics","Biotechnology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:59:45.505Z","added_via":"web","geo":{"keywords":["Alixia","Alixia","Biotech","Oncology","Drug Discovery","Healthcare","Therapeutics","Biotechnology"],"canonical_facts":["Product of Alixia"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:59:45.505Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/categories/biotechnology"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:59:45.505Z","updated_at":"2026-09-05T05:59:45.505Z"}},{"listing_type":"product","name":"Modulari-T","slug":"modulari-t-product","tagline":"Biotech platform developing next-generation modular immune receptors and in vivo gene delivery vehicles to overcome CAR-T therapy limitations.","description":"Modulari-T develops two core technologies for cell and gene therapy: MARC (Modular Actuation Receptor Complex), a next-generation immune receptor with separate targeting and signaling, on/off control, bispecific options, and reduced exhaustion validated across five cell types; and MoVe (Modular Vector), the first rationally designed in vivo delivery vehicle for gene therapy that avoids liver toxicity and precisely targets immune or non-immune cells. The platform is designed to expand cell therapies beyond hematologic malignancies to solid tumors, autoimmune diseases, and other conditions.\n\nModulari-T is a product of Modulari-T.","url":"https://modularit.bio/","is_stealth":false,"normalized_domain":"modularit.bio","normalized_url_key":"modularit.bio","parent_slug":"modulari-t","parent":{"slug":"modulari-t","name":"Modulari-T","listing_type":"company","profile_url":"/companies/modulari-t"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["cancer cell therapy","gene delivery","autoimmune disease treatment","next-generation CAR-T development"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Cell Therapy","Gene Therapy","Synthetic Biology","Therapeutics","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:49:53.383Z","added_via":"web","geo":{"keywords":["Modulari-T","Modulari-T","Biotech","Healthcare","Cell Therapy","Gene Therapy","Synthetic Biology","Therapeutics","Oncology"],"canonical_facts":["Product of Modulari-T"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:49:53.383Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/categories/cell-therapy"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:49:53.383Z","updated_at":"2026-09-05T05:49:53.383Z"}},{"listing_type":"product","name":"Adventris Pharmaceuticals","slug":"adventris-pharmaceuticals-product","tagline":"Off-the-shelf cancer vaccines targeting KRAS and other poorly immunogenic oncogenes to prevent and treat common cancers.","description":"Adventris Pharmaceuticals develops off-the-shelf cancer vaccines using a platform that solves the challenge of targeting poorly immunogenic oncogenes. Its first vaccine targets KRAS, the most common cancer oncogene. The long-term vision is annual pan-cancer vaccines for adults that could prevent the majority of cancer deaths. The company is in early-stage development and backed by Y Combinator (Winter 2023).\n\nAdventris Pharmaceuticals is a product of Adventris Pharmaceuticals.","url":"https://www.adventris.com/","is_stealth":false,"normalized_domain":"adventris.com","normalized_url_key":"adventris.com","parent_slug":"adventris-pharmaceuticals","parent":{"slug":"adventris-pharmaceuticals","name":"Adventris Pharmaceuticals","listing_type":"company","profile_url":"/companies/adventris-pharmaceuticals"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["KRAS-driven cancer treatment","pan-cancer vaccination","cancer prevention"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.adventris.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.adventris.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Drug Discovery","Therapeutics","Oncology","Drug Discovery and Delivery"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:41:10.057Z","added_via":"web","geo":{"keywords":["Adventris Pharmaceuticals","Adventris Pharmaceuticals","Healthcare","Biotech","Drug Discovery","Therapeutics","Oncology","Drug Discovery and Delivery"],"canonical_facts":["Product of Adventris Pharmaceuticals"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:41:10.057Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:41:10.057Z","updated_at":"2026-09-05T05:41:10.057Z"}},{"listing_type":"product","name":"Velorum Therapeutics","slug":"velorum-therapeutics-product","tagline":"Drug pipeline targeting heme biology to treat porphyrias, cancer, and tissue injury.","description":"Velorum Therapeutics is a clinical-stage drug development company focused on unlocking the biology of heme, an iron-containing molecule essential for oxygen transport and cellular detoxification. The pipeline targets diseases caused by dysregulated heme synthesis or transport, including porphyrias (EPP and XLP), cancer growth driven by heme consumption, and organ toxicity from heme release. Velorum aims to develop transformative medicines for patients with unmet medical needs.\n\nVelorum Therapeutics is a product of Velorum Therapeutics.","url":"https://www.velorumtx.com/","is_stealth":false,"normalized_domain":"velorumtx.com","normalized_url_key":"velorumtx.com","parent_slug":"velorum-therapeutics","parent":{"slug":"velorum-therapeutics","name":"Velorum Therapeutics","listing_type":"company","profile_url":"/companies/velorum-therapeutics"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["treating porphyrias (EPP, XLP)","targeting cancer driven by heme consumption","treating organ toxicity from heme release"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.velorumtx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.velorumtx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Drug Discovery","Therapeutics","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:40:26.901Z","added_via":"web","geo":{"keywords":["Velorum Therapeutics","Velorum Therapeutics","Healthcare","Biotech","Drug Discovery","Therapeutics","Oncology"],"canonical_facts":["Product of Velorum Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:40:26.901Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:40:26.901Z","updated_at":"2026-09-05T05:40:26.901Z"}}],"total":58,"limit":50,"offset":0}